{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03512262","recordId":"NCT03512262","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03512262-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03512262.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03512262.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2018-04-26","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"4017fdc496bb367b69a72a992cd1066d0f5852bf0928b42ed8befac70b7dd36b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-01-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-01-11","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"f3d3db689e75ec7dc7680a0cec935a0d6a9ba0e5a81f195b16debad10244c257","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-03-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-03-10","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"8b0c995faa9960e564c655322f99f7ce83de5b55a17dfb399f128eb93dc86b06","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-04-22","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"ab4877615c79e411d43cedaba179959c9d8863a461b494a69eab7bb845a8a673","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-09-21","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"1fb4a29c64fe0c3ab5089948834794ec442d5186a7ff741a6b08cb31b304157a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-07-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-07-13","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"c7768737bac06c9c629c39c7c9204c5e360da7d3f3916596dfde86154fe888c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2021-11-05","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"56bfaa86930af5df01d155ee85809c5c470a01d768c45b0f83949290c6d7dd21","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2023-04-06","publishedAt":"2026-08-23","recordId":"NCT03512262","recordSha256":"1a0aa1284709633b753d52c283ba1316ab05403ac33e93e6534316a4a493e13a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03512262?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"cc4c126c1ee2f636821e4558cc6192630b814ad4109ca1c7d557dde9e5080c1f"}}